Sorry, you need to enable JavaScript to visit this website.

Disease management

Subject Hierarchy
Broader terms
Illness
Current term
Disease management
Permalinks
APO URI

ADVERTISEMENT

Report

Understanding First Nations communities’ preparedness, concerns and strategies for addressing COVID-19: final report


This study sought to investigate the capacity of regional and remote local governments of Australian First Nations Communities to develop and deploy pandemic disaster management strategies and plans.
Policy report

COVID-19 and science for policy and society


This is the second in a series of three reports that explore how science was mobilised in response to the COVID-19 pandemic. The focus is on science for policy – research agenda setting, scientific advice and public communication and engagement.
Report

Scaling smart solutions with AI in health: unlocking impact on high-potential use cases


This report highlights high-priority use cases for public-private collaboration in healthcare. It stresses the need for a common vision and actions to unlock AI's full potential for global health. The report identifies key areas where AI can make a difference, including disease detection, outbreak management and medical breakthroughs.
Report

Covid’s cohort of losers: the intergenerational burden of coronavirus response


Australia’s young people deserve to have their interests considered in Australian policy-making. In the Covid era, many policies were defended on the basis that they would help those vulnerable to Covid, mainly the elderly. In this report, the author attempts to put a price tag on Covid-era policies, from the perspective of Australia’s youth.
Journal article

General practitioners' perceptions of the provision of direct-acting antivirals for hepatitis C within Australian private general practice: an exploratory qualitative study

This paper argues that there is a need to increase the involvement of Australian general practitioners (GPs) working in private practice to realise the potential of direct-acting antiviral treatments for people with the hepatitis C virus.